Pfizer Limited
Goldman Sachs sold 4,26,066 shares of Pfizer Limited for ₹200.25 Cr at ₹4700.01 apiece in a bulk deal.
A multinational pharmaceutical manufacturer engaged in producing, marketing, trading, and exporting medicines across India through both owned facilities and contract manufacturers positioned nationwide. The company distributes its products via independent distributors and maintains a significant presence in the domestic pharmaceutical market. Its operations span multiple therapeutic areas serving healthcare needs across the country.
US-based global investment bank (USD 1.6 trillion in assets, USD 3 trillion+ in client AUM through Goldman Sachs Asset Management). India FPI activity covers proprietary, market-making, client flows and active asset management mandates in listed Indian equities.